National Healthcare (NHC) Cash & Equivalents (2010 - 2026)

National Healthcare (NHC) has reported Cash & Equivalents for 17 consecutive years, with $39.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents fell 64.67% year-over-year to $39.2 million; the trailing twelve-month figure through Jun 2026 stood at $39.2 million (down 64.67% YoY), and the FY2025 full-year result was $92.8 million, up 21.95% from the prior year.
• Cash & Equivalents fell to $39.2 million in Q2 2026 per NHC's latest filing, from $85.5 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $136.2 million in Q2 2024 and bottomed at $39.2 million in Q2 2026.
• Historically, Cash & Equivalents has averaged $83.8 million across 5 years, with a median of $85.2 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Cash & Equivalents surged 125.34% in 2023, then tumbled 64.67% in 2026.
• Over 5 years, Cash & Equivalents stood at $58.7 million in 2022, then surged by 82.51% to $107.1 million in 2023, then fell by 28.91% to $76.1 million in 2024, then grew by 21.95% to $92.8 million in 2025, then plunged by 57.76% to $39.2 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $39.2 million, $85.5 million, and $92.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.